Trevena to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
September 05 2017 - 4:01PM
Trevena, Inc. (NASDAQ:TRVN) today announced that it will be
presenting at the 19th Annual Global Investment Conference hosted
by Rodman & Renshaw on Tuesday, September 12, 2017, at 12:05
p.m. EDT in New York.
To join a live audio webcast of the presentation, please visit
the Investor section of the Company’s website. Following the
conclusion of the presentation, the webcast will be available for
replay for 30 days.
About Trevena
Trevena, Inc. is a biopharmaceutical company developing
innovative therapies based on breakthrough science to benefit
patients and healthcare providers confronting serious medical
conditions. The Company has discovered four novel and
differentiated drug candidates, including OLINVO™ (oliceridine
injection), for the management of moderate-to-severe acute pain,
TRV250, for the treatment of acute migraine, and TRV734 for pain.
The Company maintains an early stage portfolio of drug discovery
programs.
Contacts
Trevena, Inc.
Investors:
Jonathan Violin, Ph.D.
Vice President, Corporate Strategy & Investor Relations
610-354-8840 x231
jviolin@trevena.com
or
Media:
Public Relations
PR@trevena.com
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Apr 2023 to Apr 2024